Company: OCEA
Filing Date: 2025-02-26
Form Type: DEF 14A
Source: 0001493152-25-008279
Chunk: 1

Company: Ocean Biomedical, Inc.
Filing Date: 2025-02-26
Form: DEF 14A
Chunk 1
---
 authorize the slate of directors, (ii) authorize a reverse split of our common stock of 1:2 to 1:250, (iii) authorize a new Company Incentive Plan; (iv) ratify the appointment of Berkowitz Pollack Brant, CPAs as the Company’s independent registered public accounting firm for the year ended December 31, 2024; (v) the approval, on a non-binding advisory basis, of the frequency of future stockholder advisory votes to approve the compensation of our named executive officers; and (vi) non-binding advisory vote on approval of compensation of our named executive officers.

The above matters are fully described in the Proxy Statement accompanying this Notice. Please refer to the Proxy Statement for further information with respect to the business to be transacted at the Annual Meeting. The Board of Directors unanimously recommends that you vote “FOR” the Nasdaq Proposal.

We hope you will be able to attend the Annual Meeting. Whether or not you plan to attend the Annual Meeting, we hope you will vote promptly. Information about voting methods is set forth in the accompanying proxy statement.

Thank you for your continued support of Ocean Biomedical, Inc. We look forward to seeing you at the Annual Meeting.

| By                              
 Order of the Board of Directors |
| /s/                             
 Chirinjeev Kathuria             |
| Chirinjeev                      
 Kathuria                        |
| Chairman                        |

| i |

PROXY STATEMENT

INFORMATION ABOUT THE ANNUAL MEETING AND PROXY MATERIALS

This Proxy Statement is being furnished to the stockholders of Ocean Biomedical, Inc., a Delaware corporation (the “ Company,” “ Ocean Biomedical,” “ we,” “ our” or “ us”), as of February 21, 2025 (the “ Record Date”) in connection with the solicitation of proxies for use at the 2024 Annual Meeting of Stockholders of the Company (the “ Annual Meeting”) to be held on March 28, 2025, at 9:00 a.m. Mountain Time at 2511 Redwood Road, Suite 16, Woods Cross, UT 84087. This solicitation of proxies is made on behalf of our board of directors (the “ Board”).

This Proxy Statement summarizes the information you need to know in order to vote on the proposals to be considered at the Annual Meeting in an informed manner.

We urge you to read carefully the remainder of this Proxy Statement because the information in this section may not provide all the information that you